Douglas Miehm
Stock Analyst at RBC Capital
(0)
# 4125
Out of 5,240 analysts
44
Total ratings
46.43%
Success rate
-6.44%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ligand Pharmaceutica... | Maintains: Outperform | 130 140 | 109.71 | 27.61% | 4 | Nov 12, 2024 | |
Bausch Health Compan... | Maintains: Sector Perform | 10 11 | 7.49 | 46.86% | 18 | Nov 1, 2024 | |
Bausch & Lomb | Maintains: Outperform | 20 23 | 17.3 | 32.95% | 10 | Oct 22, 2024 | |
Aurinia Pharmaceutic... | Maintains: Outperform | 13 8 | 7.71 | 3.76% | 9 | Feb 16, 2024 | |
CRH Medical | Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | n/a | n/a | n/a | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 20, 2016 |